1 These are headline figures from the company, not yet the full published data, so the detailed results still need to be checked when theyre released
The majority of all prescriptions dispensed within the benefit were for Ozempic (54.7%), and the majority outside the benefit was for Saxenda (87.8%)
Carnosine acts as a buffer during that decline
PS modifications are central to RNA-based therapeutics, generating diastereomers that improve stability, bioavailability, and cellular uptake
In subsequent studies: PIONEER-6 and ELIXA the primary endpoints (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, hospitalization for unstable angina) were not met in the GLP-1 RAs group, but a significant decrease in glycated hemoglobin was observed